Document is current
Any future updates will be listed below
-
Authors
Sanders, Georgiana M.
Hua, Alexandra
Hudson, Elizabeth
Troost, Jonathan P.
Kamada, Nobuhiko
Kao, John Y.
Schuler, Charles F. IV
El-Zaatari, Mohamad
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04644783 at ClinicalTrials.govDocuments that mention this clinical trial
Association of myeloid cell reactivity patterns with safe food predictions in FPIES patients
https://doi.org/10.1186/s13223-025-00968-1
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1TR002240)
National Institute of Allergy and Infectious Diseases (1K23AI162661)
Gerber Foundation (9026)
Bioinformatics Core of the University of Michigan Medical School’s Biomedical Research Core Facilities (RRID: SCR 019168)
Michigan Institute for Clinical and Health Research (UM1TR004404)
A. Alfred Taubman Medical Research Institute
- License Information
-
More Information
Article History
Received: 28 September 2024
Accepted: 1 May 2025
First Online: 21 May 2025
Declarations
:
: The study was approved by the Institutional Review Board (IRB) at the University of Michigan under IRB protocol # HUM00156027. Written informed consent was signed for by one one of the participants’ parents or guardians. Recruitment of FPIES participants was conducted under a single-arm clinical trial of 10 FPIES participants, registered at ClinicalTrials.gov (NCT04644783). Blood samples from 5 de-identified non-FPIES participants were collected independently of the clinical trial, serving as an external control arm under IRB protocol #HUM00208717.
: Not applicable.
: The authors declare no competing interests.
